Ledger.Open graph →
SEC Form D · filed January 15, 2014

RedHill Biopharma Ltd

Offering
$2.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
TEL AVIV, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Kenneth Reed · Tel Aviv, L3DirectorEric Swenden · Tel Aviv, L3DirectorReza Fathi · Tel Aviv, L3ExecAdi Frish · Tel Aviv, L3ExecOfer Tsimchi · Tel Aviv, L3DirectorGilead Raday · Tel Aviv, L3ExecDan Suesskind · Tel Aviv, L3DirectorAliza Rotbard · Tel Aviv, L3DirectorOri Shilo · Tel Aviv, L3Exec · DirectorDror Ben Asher · Tel Aviv, L3Exec · DirectorGuy Goldberg · Tel Aviv, L3ExecUri Hananel Aharon · Tel Aviv, L3ExecDan Suesskind · Tel Aviv, L3DirectorKenneth Reed · Waltham, MADirectorAliza Rotbard · Tel Aviv, L3DirectorEric Swenden · Tel Aviv, L3DirectorReza Fathi · Tel Aviv, L3ExecAdi Frish · Tel Aviv, L3ExecOfer Tsimchi · Tel Aviv, L3DirectorOri Shilo · Tel Aviv, L3Exec · DirectorDror Ben Asher · Tel Aviv, L3Exec · DirectorGuy Goldberg · Tel Aviv, L3ExecGilead Raday · Kefar-Uria, L3ExecUri Hananel Aharon · Tel Aviv, L3Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗